EZR and viral infectious disease: This hypothesis was investigated using Ezrin peptides, which have previously demonstrated effectiveness in treating a variety of viral infections, initiated by HIV-1, hepatitis C virus, human papillomavirus, herpes simplex I and II, and the causative viral agents in acute viral respiratory infection [37].